These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry, BioSpace.com Breaking… Source: BioSpace You Might Also Like <b>Gates</b>-Backed Cambridge Startup Affinivax Grabs $10 Million+ Deal With Japanese Drug Giant Astellas February 27, 2017 Tiny OncoSec Surges on Promising Phase II Melanoma Data November 7, 2017 Alnylam Emerges as Winner in Rare Disease Study Showdown With Ionis November 2, 2017
<b>Gates</b>-Backed Cambridge Startup Affinivax Grabs $10 Million+ Deal With Japanese Drug Giant Astellas February 27, 2017
